Table 2 Outcomes Based on Microporous Polysaccharide Hemospheres Treatment and Body Mass Index

Number of patients

21

21

25

17

Number of post-op clinic visits

1.0

1.24

1.2

1.0

Post-op complication rate

0.0%

4.8%

4.0%

0.0%

All procedures

10.0 ± 4.4 (4–23)

9.14 ± 2.9 5–16)

8.7 ± 2.8 (4–16)

10.9 ± 4.6 (6–23)

SM without SLNB

12.6 ± 6.5 (8–23)

9.8 ± 3.6 (7–15)

8.2 ± 0.8 (7–9)

15.3 ± 6.1 (8–23)

SM with SLNB

8.1 ± 3.1 (4–16)

8.2 ± 1.6 (5–11)

7.8 ± 2.1 (4–11)

8.6 ± 3.2 (6–16)

MRM

11.6 ± 2.9 (8–14)

9.9 ± 3.7 (6–16)

10.3 ± 3.8 6–16)

11 ± 2.9 (8–15)

All procedures

608.8 ± 409.7 (149–2008)

562.6 ± 294.6 (228–1289)

496.5 ± 244.9 (149–1290)

716.9 ± 446.1 (301–2008)

SM without SLNB

859.2 ± 675.9 (414–2008)

509.6 ± 299 (328–953)

391.8 ± 60.0 (328.0–459-0)

1093.9 ± 647 (482–2008)

SM with SLNB

434.2 ± 219.6 (149–996)

470.4 ± 126.4 (287–685)

432.4 ± 149.1 (149–685)

477.6 ± 227.5 (301–996)

MRM

742.7 ± 278.5 (432–1032)

692.7 ± 399.4 (228–1290)

658.1 ± 352.1 (228–1290)

798.1 ± 355.8 (432–1261)

All procedures

261.3 ± 88.3 (130–505)

253.2 ± =74.8 (155–403)

235.7 ± 66.9 (130–403)

288.7 ± 91.1 (177–505)

SM without SLNB

302.4 ± 118.2 (280–505)

198.4 ± 62.8 (155–201)

191.6 ± 37.4 (155–247)

336.9 ± 114.4 (249–505)

SM with SLNB

221 ± 59.7 (130–355)

244.1 ± 49.9 (177–330)

227.6 ± 55.4 (130–330)

237.1 ± 58.5 (177–353)

MRM

308.2 ± 82.5 (230–415)

290.8 ± 89.5 (167–403)

275.4 ± 80.0 (167–403)

332.8 ± 85.7 (221–415)